U.S. Physical Therapy, Inc. (NYSE:USPH) announced a dividend on Thursday, November 7th, Fidelity reports. Stockholders of record on Monday, November 18th will be given a dividend of 0.30 per share on Friday, December 13th. The ex-dividend date of this dividend is Friday, November 15th.
USPH stock opened at $117.50 on Friday. The company’s 50 day simple moving average is $134.71 and its 200-day simple moving average is $126.55. The firm has a market capitalization of $1.86 billion, a PE ratio of 44.34, a P/E/G ratio of 4.05 and a beta of 1.09. U.S. Physical Therapy has a 12 month low of $98.69 and a 12 month high of $148.48. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.88 and a quick ratio of 1.88.
U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.71 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.71. The business had revenue of $117.30 million for the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.64 earnings per share. As a group, sell-side analysts anticipate that U.S. Physical Therapy will post 2.94 earnings per share for the current year.
A number of equities analysts have weighed in on the stock. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price target on the stock in a research note on Friday. ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. Finally, Zacks Investment Research restated a “hold” rating on shares of U.S. Physical Therapy in a research report on Saturday, October 19th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $127.20.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: What is the price-to-earnings growth (PEG) ratio?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.